Management ChangeJun 23, 2026, 05:07 PM
Theravance Biopharma SVP Áine Miller to Depart
AI Summary
Theravance Biopharma announced that Dr. Áine Miller, Senior Vice President, Development and Head of Ireland Office, will depart the company on November 15, 2026. This termination is part of the restructuring announced by the company in March 2026. In connection with her departure, Dr. Miller will receive a special pension contribution of $250,000 and was granted 18,750 restricted share units for her continued service.
Key Highlights
- Dr. Áine Miller, SVP, Development and Head of Ireland Office, will depart.
- Her employment with Theravance Biopharma will terminate on November 15, 2026.
- The departure is in connection with the company's March 2026 restructuring.
- Company will make a special pension contribution of $250,000 for Dr. Miller.
- Dr. Miller received a grant of 18,750 restricted share units on June 19, 2026.
Price Impact
More from TBPH